{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:56:25Z","timestamp":1792029385052,"version":"4.4.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,4,6]]},"DOI":"10.1001\/jama.2021.2900","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T15:43:17Z","timestamp":1617723797000},"page":"1286","source":"Crossref","is-referenced-by-count":36,"title":["Antimicrobial Use in a Cohort of US Nursing Homes, 2017"],"prefix":"10.1001","volume":"325","author":[{"given":"Nicola D.","family":"Thompson","sequence":"first","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimalie D.","family":"Stone","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric J.","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin R.","family":"Penna","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taniece R.","family":"Eure","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"Bamberg","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment, Denver"},{"name":"Now with Medical Epidemiology Consulting, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant R.","family":"Barney","sequence":"additional","affiliation":[{"name":"New York Emerging Infections Program, Rochester"},{"name":"Now with New York State Department of Health, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devra","family":"Barter","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Clogher","sequence":"additional","affiliation":[{"name":"Connecticut Emerging Infections Program, New Haven"},{"name":"Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malini B.","family":"DeSilva","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, St Paul"},{"name":"Now with HealthPartners Institute, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghinwa","family":"Dumyati","sequence":"additional","affiliation":[{"name":"New York Emerging Infections Program, Rochester"},{"name":"University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Frank","sequence":"additional","affiliation":[{"name":"California Emerging Infections Program, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina B.","family":"Felsen","sequence":"additional","affiliation":[{"name":"New York Emerging Infections Program, Rochester"},{"name":"University of Rochester, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Godine","sequence":"additional","affiliation":[{"name":"California Emerging Infections Program, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Irizarry","sequence":"additional","affiliation":[{"name":"New Mexico Department of Health, Santa Fe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion A.","family":"Kainer","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health, Nashville"},{"name":"Now with Western Health, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Li","sequence":"additional","affiliation":[{"name":"Maryland Emerging Infections Program, Maryland Department of Health, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Lynfield","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, St Paul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. P.","family":"Mahoehney","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, St Paul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Maloney","sequence":"additional","affiliation":[{"name":"Connecticut Department of Health, Hartford"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Nadle","sequence":"additional","affiliation":[{"name":"California Emerging Infections Program, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie L. S.","family":"Ocampo","sequence":"additional","affiliation":[{"name":"Oregon Health Authority, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Pierce","sequence":"additional","affiliation":[{"name":"Oregon Health Authority, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Ray","sequence":"additional","affiliation":[{"name":"Georgia Emerging Infections Program, Atlanta"},{"name":"Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Shrum","family":"Davis","sequence":"additional","affiliation":[{"name":"New Mexico Department of Health, Santa Fe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Sievers","sequence":"additional","affiliation":[{"name":"New Mexico Department of Health, Santa Fe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krithika","family":"Srinivasan","sequence":"additional","affiliation":[{"name":"Connecticut Emerging Infections Program, New Haven"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy E.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Maryland Emerging Infections Program, Maryland Department of Health, Baltimore"},{"name":"Now with Maryland Emerging Infections Program, University of Maryland Baltimore County, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia Y.","family":"Zhang","sequence":"additional","affiliation":[{"name":"Oregon Health Authority, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley S.","family":"Magill","sequence":"additional","affiliation":[{"name":"Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"28","key":"joi210021r3","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.28.1800339","article-title":"Targets for the reduction of antibiotic use in humans in the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) partner countries.","volume":"24","author":"D\u2019Atri","year":"2019","journal-title":"Euro Surveill"},{"issue":"4","key":"joi210021r7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11908-017-0576-7","article-title":"Challenges and strategies for prevention of multidrug-resistant organism transmission in nursing homes.","volume":"19","author":"Dumyati","year":"2017","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"joi210021r8","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13670-015-0120-2","article-title":"Colonization with multi-drug resistant organisms in nursing homes: scope, importance, and management.","volume":"4","author":"Cassone","year":"2015","journal-title":"Curr Geriatr Rep"},{"issue":"4","key":"joi210021r14","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/geront\/48.4.432","article-title":"Medicare part D and the nursing home setting.","volume":"48","author":"Stevenson","year":"2008","journal-title":"Gerontologist"},{"issue":"46","key":"joi210021r15","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800394","article-title":"Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017.","volume":"23","author":"Ricchizzi","year":"2018","journal-title":"Euro Surveill"},{"issue":"12","key":"joi210021r18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1017\/ice.2016.200","article-title":"Comparison of data collection for healthcare-associated infection surveillance in nursing homes.","volume":"37","author":"Epstein","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"joi210021r20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jamda.2016.08.013","article-title":"Prevalence of antimicrobial use and opportunities to improve prescribing practices in US nursing homes.","volume":"17","author":"Thompson","year":"2016","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"joi210021r21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jamda.2019.11.009","article-title":"Epidemiology of antibiotic use for urinary tract infection in nursing home residents.","volume":"21","author":"Thompson","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"11","key":"joi210021r22","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1111\/jgs.2008.56.issue-11","article-title":"Factors associated with antimicrobial use in nursing homes: a multilevel model.","volume":"56","author":"Benoit","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"46","key":"joi210021r24","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2018.23.46.1800607","article-title":"Antimicrobials in acute and long-term care: a point in time along the way to improved use.","volume":"23","author":"Neuhauser","year":"2018","journal-title":"Euro Surveill"},{"issue":"9","key":"joi210021r25","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/pds.3196","article-title":"Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey.","volume":"21","author":"Latour","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"joi210021r26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1002\/pds.1980","article-title":"How are antibacterials used in nursing homes? results from a point-prevalence prescription study in 44 Norwegian nursing homes.","volume":"19","author":"Blix","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"joi210021r27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2165\/11595050-000000000-00000","article-title":"Antimicrobial prescribing in nursing homes in Northern Ireland: results of two point-prevalence surveys.","volume":"28","author":"McClean","year":"2011","journal-title":"Drugs Aging"},{"issue":"7","key":"joi210021r28","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/jac\/dkz135","article-title":"Antimicrobial use in UK long-term care facilities: results of a point prevalence survey.","volume":"74","author":"Thornley","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"joi210021r29","doi-asserted-by":"publisher","first-page":"200","DOI":"10.18773\/austprescr.2019.066","article-title":"The 2018 Aged Care National Antimicrobial Prescribing Survey: results show room for improvement.","volume":"42","author":"Dowson","year":"2019","journal-title":"Aust Prescr"},{"issue":"8","key":"joi210021r30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1017\/ice.2017.96","article-title":"Measuring antibiotic appropriateness for urinary tract infections in nursing home residents.","volume":"38","author":"Eure","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"joi210021r31","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jamda.2019.11.004","article-title":"Diagnosis, treatment, and prevention of urinary tract infections in post-acute and long-term care settings: a consensus statement from AMDA\u2019s infection advisory subcommittee.","volume":"21","author":"Ashraf","year":"2020","journal-title":"J Am Med Dir Assoc"},{"issue":"10","key":"joi210021r32","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/jgs.2018.66.issue-10","article-title":"Outpatient antibiotic prescribing for older adults in the United States: 2011 to 2014.","volume":"66","author":"Kabbani","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"joi210021r33","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1093\/cid\/ciy035","article-title":"Opportunities to improve fluoroquinolone prescribing in the United States for adult ambulatory care visits.","volume":"67","author":"Kabbani","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9","key":"joi210021r34","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients.","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"joi210021r35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study.","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"joi210021r36","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1017\/ice.2020.183","article-title":"Prescriber perceptions of fluoroquinolones, extended-spectrum cephalosporins, and Clostridioides difficile infection.","volume":"41","author":"Szymczak","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"joi210021r37","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jamda.2019.11.010","article-title":"Reducing fluoroquinolone use and clostridioides difficile infections in community nursing homes through hospital-nursing home collaboration.","volume":"21","author":"Felsen","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"joi210021r1","unstructured":"World Health Organization. Fact sheet. Antimicrobial resistance. February 15, 2018. Accessed March 16, 2021.? https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"joi210021r2","unstructured":"Centers for Disease Control and Prevention. About TATFAR (Transatlantic Taskforce on Antimicrobial Resistance). Updated September 10, 2018. Accessed March 16, 2021.? https:\/\/www.cdc.gov\/drugresistance\/tatfar\/about.html"},{"key":"joi210021r4","unstructured":"The White House. National Strategy for Combating Antibiotic-Resistant Bacteria. September 2014. Accessed March 16, 2021.? https:\/\/obamawhitehouse.archives.gov\/sites\/default\/files\/docs\/carb_national_strategy.pdf"},{"key":"joi210021r5","unstructured":"Centers for Disease Control and Prevention. US National Action Plan for Combating Antibiotic-Resistant Bacteria (National Action Plan). Published October 2020. Accessed March 16, 2021.? https:\/\/www.cdc.gov\/drugresistance\/us-activities\/national-action-plan.html"},{"key":"joi210021r6","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. Accessed March 16, 2021.? https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html"},{"key":"joi210021r9","unstructured":"Tian? W; Agency for Healthcare Research and Quality. An all-payer view of hospital discharge to postacute care, 2013. HCUP statistical brief #205. May 2016. Accessed March 16, 2021.? https:\/\/www.hcup-us.ahrq.gov\/reports\/statbriefs\/sb205-Hospital-Discharge-Postacute-Care.jsp"},{"key":"joi210021r10","unstructured":"American Healthcare Association; National Center for Assisted Living. Quality report, 2013. Accessed March 16, 2021.? https:\/\/www.nyshfa-nyscal.org\/files\/2018\/11\/AHCA-Quality-Report-2013.pdf"},{"key":"joi210021r11","unstructured":"Centers for Medicare & Medicaid Services. Nursing Home Data Compendium, 2015 Edition. Accessed March 16, 2021.? https:\/\/www.cms.gov\/Medicare\/Provider-Enrollment-and-Certification\/CertificationandComplianc\/Downloads\/nursinghomedatacompendium_508-2015.pdf"},{"key":"joi210021r12","unstructured":"Centers for Disease Control and Prevention. Core elements of antibiotic stewardship for nursing homes. Accessed March 16, 2021.? https:\/\/www.cdc.gov\/longtermcare\/prevention\/antibiotic-stewardship.html"},{"key":"joi210021r13","unstructured":"Centers for Medicare & Medicaid Services. Reform of Requirements for Long-Term Care Facilities: Final Rule (CMS-3260-F). Accessed March 16, 2021.? https:\/\/www.federalregister.gov\/documents\/2016\/10\/04\/2016-23503\/medicare-and-medicaid-programs-reform-of-requirements-for-long-term-care-facilities"},{"key":"joi210021r16","unstructured":"Centers for Disease Control and Prevention. Emerging infections program\/healthcare-associated infections\u2014community interface (HAIC). Accessed March 16, 2021.? https:\/\/www.cdc.gov\/hai\/eip\/index.html"},{"key":"joi210021r17","unstructured":"Centers for Medicare & Medicaid Services. Nursing Home Compare datasets. Accessed March 16, 2021. https:\/\/data.medicare.gov\/data\/Nursing-Home-Compare"},{"key":"joi210021r19","unstructured":"World Health Organization Collaboration Centre for Drug Statistics Methodology. ATC structure and principles. Accessed March 16, 2021.? https:\/\/www.whocc.no\/atc\/structure_and_principles\/"},{"key":"joi210021r23","unstructured":"Centers for Disease Control and Prevention. Transatlantic Taskforce on Antimicrobial Resistance (TATFAR) data for action: using available data sources at the country level to track antibiotic use. Accessed March 16, 2021. https:\/\/www.cdc.gov\/drugresistance\/tatfar\/pdf\/Using-Available-Data-Sources-Track-Antibiotic-Use-508.pdf"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2778111\/jama_thompson_2021_oi_210021_1617663007.92274.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T15:43:34Z","timestamp":1617723814000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2778111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,4,6]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.2900","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,6]]}}}